Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463007 · ClinicalTrials.gov registry record · NA
Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer
A NA study of Breast Cancer, sponsored by Jaroslaw Hepel.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT01463007: Completed NA study of Breast Cancer, sponsored by Jaroslaw Hepel.
NCT01463007 is a NA study of Breast Cancer that has completed, run by Jaroslaw Hepel. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01463007, a NA study of Breast Cancer, has completed, sponsored by Jaroslaw Hepel.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.
Primary Outcome
Any toxicity related to the radiation treatment will be scored and graded using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v3.0 (Appendix 4). Acute side effects are any side effects occurring within 3 months of treatment. Intermediate side effects are any side effects occurring between 3 months and 2 years. This is reported in the outcome table.
Conditions Studied
Interventions
- RADIATION Accelerated partial breast irradiation
- OTHER Extended Follow up
Study Locations (4)
Rhode Island
- Brown University Oncology Research Group - Providence
- Lifespan Hospitals - Providence
Florida
- Center For Cancer Care and Research- Watson Clinic - Lakeland
Washington
- Tacoma Radiation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-08 |
| Est. Completion | 2021-04-06 |
| Phase | NA |
What the finished NCT01463007 record still lists
NCT01463007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Accelerated partial breast irradiation is the first listed.
NCT01463007 reports a single indexed study location in Rhode Island, Florida, Washington.
Frequently Asked Questions
What is clinical trial NCT01463007 about?
NCT01463007 is a clinical study titled "Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer". The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.
What is the current status of trial NCT01463007?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-08. Estimated completion is 2021-04-06.
What conditions does trial NCT01463007 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01463007?
The interventions under investigation include: Accelerated partial breast irradiation (RADIATION), Extended Follow up (OTHER).
Who is sponsoring clinical trial NCT01463007?
This trial is sponsored by Jaroslaw Hepel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01463007 being conducted?
This trial has 4 study locations across Florida, Rhode Island, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01463007's enrollment target sits among peer trials
40 876th of 1224 higher than 325 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia